Long non-coding RNA H19 increases bladder cancer metastasis by associating with EZH2 and inhibiting E-cadherin expression

Cancer Letters

Volumn 333, Issue 2, 2013, Pages 213-221

  Luo, Ming ^a   Li, Zuowei ^b   Wang, Wei ^b   Zeng, Yigang ^b   Liu, Zhihong ^b   Qiu, Jianxin ^b  

^a TONGJI UNIVERSITY   (China)

^b SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Bladder cancer metastasis; E cadherin; EZH2; H19; LncRNA

Indexed keywords

BETA CATENIN; SMALL UNTRANSLATED RNA; SMALL UNTRANSLATED RNA H19; TRANSCRIPTION FACTOR EZH2; UNCLASSIFIED DRUG; UVOMORULIN; WNT PROTEIN;

ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BINDING AFFINITY; BLADDER CANCER; CARCINOGENESIS; CELL ADHESION; CELL MIGRATION; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVATION; FEMALE; GENE EXPRESSION PROFILING; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; MALE; METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; UPREGULATION; WNT SIGNALING PATHWAY;

ADULT; AGED; ANIMALS; BETA CATENIN; CADHERINS; ENHANCER ELEMENTS, GENETIC; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MICE; MICE, INBRED C57BL; MIDDLE AGED; POLYCOMB REPRESSIVE COMPLEX 2; RNA, LONG UNTRANSLATED; URINARY BLADDER NEOPLASMS; WNT SIGNALING PATHWAY;

EID: 84876714385     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2013.01.033     Document Type: Article

References (38)

1. Lacey J.V., Devesa S.S., Brinton L.A. Recent trends in breast cancer incidence and mortality. Environ. Mol. Mutagen. 2002, 39:82-88.
2. Egerod F.L., Bartels A., Fristrup N., Borre M., Orntoft T.F., Oleksiewicz M.B., Brunner N., Dyrskjot L. High frequency of tumor cells with nuclear Egr-1 protein expression in human bladder cancer is associated with disease progression. BMC Cancer 2009, 9:385.
3. Bo J., Yang G., Huo K., Jiang H., Zhang L., Liu D., Huang Y. MicroRNA-203 suppresses bladder cancer development by repressing bcl-w expression. FEBS J 2011, 278:786-792.
4. W.J. Kim, E.J. Kim, S.K. Kim, Y.J. Kim, Y.S. Ha, P. Jeong, M.J. Kim, S.J. Yun, K.M. Lee, S.K. Moon, S.C. Lee, E.J. Cha, S.C. Bae, Predictive value of progression-related gene classifier in primary non-muscle invasive bladder cancer. Mol. Cancer 9 (2010) 3.
5. Lai M.C., Yang Z., Zhou L., Zhu Q.Q., Xie H.Y., Zhang F., Wu L.M., Chen L.M., Zheng S.S. Long non-coding RNA MALAT-1 overexpression predicts tumor recurrence of hepatocellular carcinoma after liver transplantation. Med. Oncol. 2012, 29:1810-1816.
6. Matouk I.J., Mezan S., Mizrahi A., Ohana P., Abu-Lail R., Fellig Y., Degroot N., Galun E., Hochberg A. The oncofetal H19 RNA connection: hypoxia, p53 and cancer. Biochim. Biophys. Acta 1803, 2010:443-451.
7. Benetatos L., Vartholomatos G., Hatzimichael E. MEG3 imprinted gene contribution in tumorigenesis. Int. J. Cancer 2011, 129:773-779.
8. Zhang X., Gejman R., Mahta A., Zhong Y., Rice K.A., Zhou Y., Cheunsuchon P., Louis D.N., Klibanski A. Maternally expressed gene 3, an imprinted noncoding RNA gene, is associated with meningioma pathogenesis and progression. Cancer Res. 2010, 70:2350-2358.
9. Gupta R.A., Shah N., Wang K.C., Kim J., Horlings H.M., Wong D.J., Tsai M.C., Hung T., Argani P., Rinn J.L., Wang Y., Brzoska P., Kong B., Li R., West R.B., van de Vijver M.J., Sukumar S., Chang H.Y. Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis. Nature 2010, 464:1071-1076.
10. Kogo R., Shimamura T., Mimori K., Kawahara K., Imoto S., Sudo T., Tanaka F., Shibata K., Suzuki A., Komune S., Miyano S., Mori M. Long non-coding RNA HOTAIR regulates Polycomb-dependent chromatin modification and is associated with poor prognosis in colorectal cancers. Cancer Res. 2011, 71:6320-6326.
11. Cao Q., Yu J., Dhanasekaran S.M., Kim J.H., Mani R.S., Tomlins S.A., Mehra R., Laxman B., Cao X., Kleer C.G., Varambally S., Chinnaiyan A.M. Repression of E-cadherin by the polycomb group protein EZH2 in cancer. Oncogene 2008, 27:7274-7284.
12. Kaneko S., Li G., Son J., Xu C.F., Margueron R., Neubert T.A., Reinberg D. Phosphorylation of the PRC2 component Ezh2 is cell cycle-regulated and up-regulates its binding to ncRNA. Genes Dev. 2010, 24:2615-2620.
13. Tsai M.C., Manor O., Wan Y., Mosammaparast N., Wang J.K., Lan F., Shi Y., Segal E., Chang H.Y. Long noncoding RNA as modular scaffold of histone modification complexes. Science 2010, 329:689-693.
14. Wang C., Liu X., Chen Z., Huang H., Jin Y., Kolokythas A., Wang A., Dai Y., Wong D.T., Zhou X. Polycomb group protein EZH2-mediated E-cadherin repression promotes metastasis of oral tongue squamous cell carcinoma. Mol. Carcinogen. 2011.
15. Matouk I.J., DeGroot N., Mezan S., Ayesh S., Abu-lail R., Hochberg A., Galun E. The H19 non-coding RNA is essential for human tumor growth. PLoS ONE 2007, 2:e845.
16. Yang F., Bi J., Xue X., Zheng L., Zhi K., Hua J., Fang G. Up-regulated long non-coding RNA H19 contributes to proliferation of gastric cancer cells. FEBS J. 2012.
17. Ying L., Chen Q., Wang Y., Zhou Z., Huang Y., Qiu F. Upregulated MALAT-1 contributes to bladder cancer cell migration by inducing epithelial-to-mesenchymal transition. Mol. Biosyst. 2012, 8:2289-2294.
18. Tano K., Mizuno R., Okada T., Rakwal R., Shibato J., Masuo Y., Ijiri K., Akimitsu N. MALAT-1 enhances cell motility of lung adenocarcinoma cells by influencing the expression of motility-related genes. FEBS Lett. 2010, 584:4575-4580.
19. Wan Y., Chang H.Y. HOTAIR: Flight of noncoding RNAs in cancer metastasis. Cell Cycle 2010, 9:3391-3392.
20. Zhang Y., Wei W., Cheng N., Wang K., Li B., Jiang X., Sun S. Hepatitis C Virus-induced upregulation of miR-155 promotes hepatocarcinogenesis by activating Wnt signaling. Hepatology 2012, 56:1631-1640.
21. Li Y., Hively W.P., Varmus H.E. Use of MMTV-Wnt-1 transgenic mice for studying the genetic basis of breast cancer. Oncogene 2000, 19:1002-1009.
22. Yook J.I., Li X.Y., Ota I., Hu C., Kim H.S., Kim N.H., Cha S.Y., Ryu J.K., Choi Y.J., Kim J., Fearon E.R., Weiss S.J. A Wnt-Axin2-GSK3beta cascade regulates Snail1 activity in breast cancer cells. Nat. Cell Biol. 2006, 8:1398-1406.
23. Jiang Y.G., Luo Y., He D.L., Li X., Zhang L.L., Peng T., Li M.C., Lin Y.H. Role of Wnt/beta-catenin signaling pathway in epithelial-mesenchymal transition of human prostate cancer induced by hypoxia-inducible factor-1alpha. Int. J. Urol. 2007, 14:1034-1039.
24. Xie C.G., Wei S.M., Chen J.M., Xu X.F., Cai J.T., Chen Q.Y., Jia L.T. Down-regulation of GEP100 causes increase in E-cadherin levels and inhibits pancreatic cancer cell invasion. PLoS ONE 2012, 7:e37854.
25. Kapranov P., Willingham A.T., Gingeras T.R. Genome-wide transcription and the implications for genomic organization. Nat. Rev. Genet. 2007, 8:413-423.
26. Washietl S., Hofacker I.L., Lukasser M., Huttenhofer A., Stadler P.F. Mapping of conserved RNA secondary structures predicts thousands of functional noncoding RNAs in the human genome. Nat. Biotechnol. 2005, 23:1383-1390.
27. Gibb E.A., Brown C.J., Lam W.L. The functional role of long non-coding RNA in human carcinomas. Mol. Cancer 2011, 10:38.
28. Mercer T.R., Dinger M.E., Mattick J.S. Long non-coding RNAs: insights into functions. Nat. Rev. Genet. 2009, 10:155-159.
29. Wilusz J.E., Sunwoo H., Spector D.L. Long noncoding RNAs: functional surprises from the RNA world. Genes Dev. 2009, 23:1494-1504.
30. Barsyte-Lovejoy D., Lau S.K., Boutros P.C., Khosravi F., Jurisica I., Andrulis I.L., Tsao M.S., Penn L.Z. The c-Myc oncogene directly induces the H19 noncoding RNA by allele-specific binding to potentiate tumorigenesis. Cancer Res. 2006, 66:5330-5337.
31. Chua H.L., Bhat-Nakshatri P., Clare S.E., Morimiya A., Badve S., Nakshatri H. NF-kappaB represses E-cadherin expression and enhances epithelial to mesenchymal transition of mammary epithelial cells: potential involvement of ZEB-1 and ZEB-2. Oncogene 2007, 26:711-724.
32. Eger A., Stockinger A., Schaffhauser B., Beug H., Foisner R. Epithelial mesenchymal transition by c-Fos estrogen receptor activation involves nuclear translocation of beta-catenin and upregulation of beta-catenin/lymphoid enhancer binding factor-1 transcriptional activity. J. Cell Biol. 2000, 148:173-188.
33. Ying L., Chen Q., Wang Y., Zhou Z., Huang Y., Qiu F. Upregulated MALAT-1 contributes to bladder cancer cell migration by inducing epithelial-to-mesenchymal transition. Mol. Biosyst. 2012.
34. Woo C.J., Kingston R.E. HOTAIR lifts noncoding RNAs to new levels. Cell 2007, 129:1257-1259.
35. Yang F., Bi J., Xue X., Zheng L., Zhi K., Hua J., Fang G. Up-regulated long non-coding RNA H19 contributes to proliferation of gastric cancer cells. FEBS J. 2012, 279:3159-3165.
36. Colnot S., Niwa-Kawakita M., Hamard G., Godard C., Le Plenier S., Houbron C., Romagnolo B., Berrebi D., Giovannini M., Perret C. Colorectal cancers in a new mouse model of familial adenomatous polyposis: influence of genetic and environmental modifiers. Lab. Invest. 2004, 84:1619-1630.
37. Dugimont T., Montpellier C., Adriaenssens E., Lottin S., Dumont L., Iotsova V., Lagrou C., Stehelin D., Coll J., Curgy J.J. The H19 TATA-less promoter is efficiently repressed by wild-type tumor suppressor gene product p53. Oncogene 1998, 16:2395-2401.
38. Park I.Y., Sohn B.H., Choo J.H., Joe C.O., Seong J.K., Lee Y.I., Chung J.H. Deregulation of DNA methyltransferases and loss of parental methylation at the insulin-like growth factor II (Igf2)/H19 loci in p53 knockout mice prior to tumor development. J. Cell. Biochem. 2005, 94:585-596.